PurposeC-terminal part of the split-CreERT2 System
|Item||Catalog #||Description||Quantity||Price (USD)|
|Plasmid||106371||Standard format: Plasmid sent in bacteria as agar stab||1||$75|
This material is available to academics and nonprofits only.
Vector typeMammalian Expression, Cre/Lox
Growth in Bacteria
Copy numberHigh Copy
Insert Size (bp)2106
- Promoter CMV
/ Fusion Protein
- c-myc (N terminal on backbone)
- Cloning method Restriction Enzyme
- 5′ cloning site unknown (unknown if destroyed)
- 3′ cloning site unknown (unknown if destroyed)
- 5′ sequencing primer CMV-F (Common Sequencing Primers)
Terms and Licenses
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
For your Materials & Methods section:pCMV-Tag3B-ERT2CCre was a gift from Johannes Hirrlinger (Addgene plasmid # 106371 ; http://n2t.net/addgene:106371 ; RRID:Addgene_106371)
For your References section:Split-CreERT2: temporal control of DNA recombination mediated by split-Cre protein fragment complementation. Hirrlinger J, Requardt RP, Winkler U, Wilhelm F, Schulze C, Hirrlinger PG. PLoS One. 2009 Dec 16;4(12):e8354. doi: 10.1371/journal.pone.0008354. 10.1371/journal.pone.0008354 PubMed 20016782